Skip to main content

Hypercalciuria

  • Chapter
Calculus Disease

Part of the book series: New Clinical Applications ((NCNG,volume 2))

  • 41 Accesses

Abstract

The majority of patients who form stones within the urinary tract have an associated metabolic disorder. A relationship between the increased excretion of calcium in the urine in patients with renal and ureteric calculi was first noted by Flocks1,2 but it was Albright3 who, in 1953, first coined the term ‘idiopathic hypercalciuria’, suggesting that the condition might have a tubular origin and drawing attention to the hypophosphataemia which is often present. A few years later, Henneman et al.4 demonstrated high calcium absorption, and, subsequently, Jackson and Dancaster5 suggested that this hyper-absorpiion was an adaptation to the increased urinary calcium loss. No cause can be identified in nearly all normocalcaemic hypercalciuric patienss and an autosomal dominant mode of inheritance has been suggested6. The prevalence of hypercalciuria is approximately 5% in otherwise normal adults, and, in 95% of these subjects, hypercalciuria is silent and not associated with stone formation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Flocks, R. H. (1939). Calcium and phosphorus excretion in the urine of patients with renal or ureteral calculi. J. Am. Med. Assoc., 113, 1466–7l

    CAS  Google Scholar 

  2. Flocks, R. H. (1940). Calcium urolithiasis: the role of calcium and metabolism in the pathogenesis and treatment of calcium urolithiasis. J. Urol. (Baltimore), 43, 214–33

    CAS  Google Scholar 

  3. Albright, F., Henneman, P., Benedict, P. H. and Forbes A. P. (1953). Idiopathic hypercalciuria. Proc. R. Soc. Med., 46, 1077–81

    PubMed  CAS  Google Scholar 

  4. Henneman, P. H., Benedict, P. H., Forbes, A. P. and Dudley H. R. (1958). Idiopathic hypercalciuria: importance of dietary calcium in the definition of hypercalciuria. N. Engl. J. Med., 259, 802–7

    Article  PubMed  CAS  Google Scholar 

  5. Jackson, W. P. U. and Dancaster, C. (1959). A consideration of the hypercalciuria in sarcoidosis, idiopathic hypercalciuria and that produced by vitamin D. A new suggestion regarding calcium metabolism. J. Clin. Endocrinol. Metab., 19, 658–80

    Article  PubMed  CAS  Google Scholar 

  6. Mehes, K. and Szelid, Z. (1980). Autosomal dominant inheritance of hypercalciuria. Eur. J. Paediatr., 133, 239–42

    Article  CAS  Google Scholar 

  7. Sutton, R. A. L. and Dirks, J. H. (1978). Renal handling of calcium. Fed. Proc., 37, 2112–19

    PubMed  CAS  Google Scholar 

  8. Costanzo, L. S. and Windhager, E. E. (1980). Effects of PTH ADH and cyclic AMP on distal tubular Ca and Na reabsorption. Am. J. Physiol., 239, f478–85

    PubMed  CAS  Google Scholar 

  9. Shareghi, G. R. and Stoner, L. C. (1978). Calcium transport across segments of the rabbit distal nephron in vitro. Am. J. Physiol., 235, f367–75

    PubMed  CAS  Google Scholar 

  10. Broadus, A. E. and Thier, S. O. (1979). The metabolic basis of renal stone disease. N. Engl. J. Med., 300, 839–45

    Article  PubMed  CAS  Google Scholar 

  11. Robertson, W. G., Peacock, M., Marshall, D. H. and Speed R. (1981). The prevalence of urinary stone disease in practising vegetarians. Fortschr. Urol. Nephrol., 17, 6–14

    Google Scholar 

  12. Lemann, J., Adams, N. D. and Gray R. W. (1979). Urinary calcium excretion in human beings. N. Engl. J. Med., 301, 535–41

    Article  PubMed  CAS  Google Scholar 

  13. Whiting, S. J. and Draper, H. H. (1980). The role of sulphate in the calciuria of high protein diet in the rat J. Nutr., 110, 212–22

    PubMed  CAS  Google Scholar 

  14. Linkswiler, H. M., Joyce, C. L. and Arnaud, C. R. (1974). Calcium retention of young adult males as affected by level of protein and of calcium intake. Trans. N.Y. Acad. Sci., 36, 333–40

    PubMed  CAS  Google Scholar 

  15. Goldfarb, S., Westby, G. R., Goldberg, M. and Agus, Z. S. (1977). Renal tubular effects of chronic phosphate depletion. J. Clin. Invest., 59, 770–8

    Article  PubMed  CAS  Google Scholar 

  16. Dominguez, J. H., Gray, R. W. and Lemann, J. Jr. (1976). Dietary phosphate deprivation in women and men: effects on mineral and acid balances, parathyroid hormone and the metabolism of 25(OH) vitamin D. J. Clin. Endocrinol. Metab., 43, 1056–68

    Article  CAS  Google Scholar 

  17. Lemann, J. Jr., Lennon, E. J., Piering, W. R., Prien, E. L. Jr. and Ricanati, E. S. (1970). Evidence that glucose ingestion inhibits net renal tubular reabsorption of calcium and magnesium in man. J. Lab. Clin. Med., 75, 578–85

    PubMed  CAS  Google Scholar 

  18. Sutton, R. A. L., Wong, N. L. M. and Dirks, J. H. (1979). Effects of metabolic acidosis and alkalosis on sodium and calcium transport in the dog kidney. Kidney Int., 15, 520–33

    Article  PubMed  CAS  Google Scholar 

  19. Batlle, D. C., Itsarayounguen, K., Hays, S., Arruda, J. A. L. and Kurtzman, N. A. (1982). Parathyroid hormone is not anticalciuric during chronic metabolic acidosis. Kidney Int., 22, 264–71

    Article  PubMed  CAS  Google Scholar 

  20. Peraino, R. A. and Suki, W. N. (1980). Urine HCO3- augments renal Ca++ absorption independent of systemic acid based changes. Am. J. Physiol., 238, f394–8

    PubMed  CAS  Google Scholar 

  21. Robertson, W. G., Gallagher, J. C., Marshall, D. H., Peacock, M. and Nordin, B. E. C. (1974). Seasonal variations in urinary excretion of calcium. Br. Med. J., 41, 436–7

    Article  Google Scholar 

  22. Robertson, W. G. and Morgan D. B. (1972). The distribution of urinary calcium excretions in normal persons and stone formers. Clin. Chim. Acta, 37, 503–8

    Article  PubMed  CAS  Google Scholar 

  23. Evans, R. A., Hills, E., Wong, S. Y. P., Wyndham, L. E., Eade, Y. and Dunstan, C. R. (1984). The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction. Q. J. Med., 53, 41–53

    PubMed  CAS  Google Scholar 

  24. Stanbury, S. W. (1980). Idiopathic hypercalciuria (absorptive hypercalciuria). In Norman, A. W. (ed.) Vitamin D: Molecular Biology and Clinical Nutrition, pp. 300–2. (New York: Marcel Dekker)

    Google Scholar 

  25. Shen, F. H., Baylink, D. J., Nielsen, R. L., Sherrard, D. J., Ivey, J. L. and Haussler, M. R. (1977). Increased serum 1,25-dihydroxy vitamin D in idiopathic hypercalciuria. J. Lab. Clin. Med., 90, 955–62

    PubMed  CAS  Google Scholar 

  26. Gray, R. W., Wilz, D. R., Caldas A. E. and Lemann, J. (1977). The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab., 45, 299–306

    Article  PubMed  CAS  Google Scholar 

  27. Broadus, A. E., Dominguez, M. and Bartter, F. C. (1978). Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterise distinctive hypercalciuric groups. J. Clin. Endocrinol. Metab., 47, 751–60

    Article  PubMed  CAS  Google Scholar 

  28. Pak C. Y. C., Britton F., Peterson R., Ward D., Northcutt C., Breslau N. A., McGuire J., Sakhaee K., Bush S., Nicar M., Norman D.A., and Peters P. (1980). Ambulatory evaluation of nephrolithiasis. Am. J. Med., 69, 19–30

    Article  PubMed  CAS  Google Scholar 

  29. Broadus A. E., Horst R. L., Littledike E. T., Mahaffey J. E. and Rasmussen H. (1980). Primary hyperparathyroidism with intermittent hypercalcaemia: serial observations and simple diagnosis by means of an oral calcium tolerance test. Clin. Endocrinol., 12, 225–35

    Article  CAS  Google Scholar 

  30. Broadus, A. E., Horst, R. L., Lang, R., Littledike, E. T. and Rasmussen, H. (1980). The importance of circulating 1,25-dihydroxy vitamin D in the pathogenesis of hypercalciuria and renal stone formation in primary hyperparathyroidism. N. Engl. J. Med., 302, 421–6

    Article  PubMed  CAS  Google Scholar 

  31. Pak, C. Y. C., Kaplan, R., Bone, H., Townsend, J. and Waters, O. (1975). A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N. Engl. J. Med., 292, 497–500

    Article  PubMed  CAS  Google Scholar 

  32. Tschöpe, W. and Ritz, E. (1985). Hypercalciuria and nephrolithiasis. Contr. Nephrol., 49, 94–103

    Google Scholar 

  33. Marshall, V., White, R. H., Chaput de Saintonge, D. M., Tresidder, G. C. and Blandy, J. P. (1975). The natural history of renal and ureteric calculi. Br. J. Urol., 47, 117–24

    Article  PubMed  CAS  Google Scholar 

  34. Laerum, E. and Larsen, S. (1984). Thiazide prophylaxis of urolithiasis: a double-blind study in general practice. Acta Med. Scand., 215, 383–9

    Article  PubMed  CAS  Google Scholar 

  35. Backman, U., Danielson, B. G., Johansson, S., Ljunghall, S. and Wilkström, B. (1979). Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones. Br. J. Urol., 51, 175–80

    Article  PubMed  CAS  Google Scholar 

  36. Scholz, D., Schwille, P. O. and Sigel, A. (1982). Double-blind study with thiazide in recurrent calcium lithiasis. J. Urol., 128, 903–7

    PubMed  CAS  Google Scholar 

  37. Ettinger, B. (1979). Recurrence of nephrolithiasis. A six-year prospective study. Am. J. Med., 67, 245–8

    Article  PubMed  CAS  Google Scholar 

  38. Pak, C. Y. C., Sakhaee, K., Crowther, C. and Brinkley, L. (1980). Evidence justifying a high fluid intake in treatment of nephrolithiasis. Ann. Intern. Med., 93, 36–9

    PubMed  CAS  Google Scholar 

  39. Robertson, W. G., Peacock, M., Heyburn, P. J. and Hanes, F. A. (1980). Epidemiologccal risk factors in calcium stone disease. Scand. J. Urol. Nephrol. (Suppl.), 53, 15–28

    CAS  Google Scholar 

  40. Frank, M. and De Vries, A. (1966). Prevention of urolithiasis. Arch. Environ. Health, 13, 625–30

    PubMed  CAS  Google Scholar 

  41. Baker, L. R. I. and Mallinson, W. J. W. (1979). Dietary treatment of idiopathic hypercalciuria. Br. J. Urol., 51, 181–3

    Article  PubMed  CAS  Google Scholar 

  42. Brockis, J. G., Levitt, A. J. and Cruthers, S. M. (1982). The effects of vegetable and animal protein diets on calcium, urate and oxalate excretion. Br. J. Urol., 54, 590–3

    Article  PubMed  CAS  Google Scholar 

  43. Heaton K. W. and Pomare E. W. (1974). Effect of bran on blood lipids and calcium. Lancet, 1, 49–50

    Article  PubMed  CAS  Google Scholar 

  44. Shah, P. J. R., Williams, G. and Green, N. A. (1980). Idiopathic hypercalciuria: its control with unprocessed bran. Br. J. Urol., 52, 426–9

    Article  PubMed  CAS  Google Scholar 

  45. Yendt E. R. and Cohanim M. (1978). Thiazides in calcium urolithiasis. Can. Med. Assoc. J., 118, 755–8

    PubMed  CAS  Google Scholar 

  46. Zerwekh J. E. and Pak C. Y. C. (1980) Selective effects of thiazide therapy on serum 1α, 25-dihydroxy vitamin D and intestinal calcium absorption in renal absorptive hypercalciurias. Metabolism, 29, 13–17

    Article  PubMed  CAS  Google Scholar 

  47. Barilla, D. E., Tolentino, R., Kaplan, R. A. and Pak, C. Y. C. (1978). Selective effects of thiazide on intestinal absorption of calcium in absorptive and renal hypercalciuria. Metabolism, 27, 125–31

    Article  PubMed  CAS  Google Scholar 

  48. Brocks P., Dahl C., Wolf H. and Transbol I. (1981). Do thiazides prevent recurrent idiopathic renal calcium stones? Lancet, 2, 124–5

    Article  PubMed  CAS  Google Scholar 

  49. Pak C. Y. C., Nicar M., and Northcutt C. (1982). The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers. Contrib. Nephrol., 33, 136–51

    PubMed  CAS  Google Scholar 

  50. Meyer, J. L. and Thomas, W. C. Jr. (1982). Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. I. Effects of Fe(III), Cr(III), and Al(III) complexes on calcium phosphate crystal growth. J. Urol., 128, 1372–5

    PubMed  CAS  Google Scholar 

  51. Bisaz, S., Felix, R., Neuman, W. and Fleisch, H. (1978). Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Min. Electrolyte Metab., 1, 74–83

    CAS  Google Scholar 

  52. Meyer, J. L. and Smith, L. H. (1975). Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest. Urol., 13, 36–9

    PubMed  CAS  Google Scholar 

  53. Meyer, J. L. and Thomas, W. C. (1982). Trace metal-citric acid complexes as inhibitoss of calcification and crystal growth. II. Effects of Fe(III), Cr(III), and Al(III), complexes on calcium oxalate crystal growth. J. Urol., 128, 1376–8

    PubMed  CAS  Google Scholar 

  54. Nicar, M.J., Peterson, R. and Pak, C. Y. C. (1984). Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J. Urol., 131, 430–3

    PubMed  CAS  Google Scholar 

  55. Pak, C. Y. C. (1973). Sodium cellulose phosphate: mechanism of action and effect on mineral metabolism. J. Clin. Pharmacol., 13, 15–27

    CAS  Google Scholar 

  56. Backman, U., Danielson, B. G., Johansson, G., Ljunghall, S. and Wikström, B. (1980). Treatment of recurrent calcium stone formation with cellulose phosphate. J. Urol., 123, 9–13

    PubMed  CAS  Google Scholar 

  57. Pak, C. Y. C. (1981). A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis. Invest. Urol., 19, 187–90

    PubMed  CAS  Google Scholar 

  58. Fleisch, H., Bisaz, S. and Care, A. D. (1964). Effect of orthophosphates on urinary pyrophosphate excretion and the prevention of urolithiasis. Lancet, 1, 1065–7

    Article  PubMed  CAS  Google Scholar 

  59. Thomas, W. C. Jr. (1971). Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi. Trans. Am. Clin. Climatol. Assoc., 83, 113–24

    Google Scholar 

  60. Ettinger, B. (1976). Recurrent nephrolithiasis: natural history and effect of phosphate therapy. Am. J. Med., 61, 200–6

    Article  PubMed  CAS  Google Scholar 

  61. Lau, K., Wolf, C., Nussbaum, P., Weiner, B., De Oreo, P., Slatopolsky, E., Agus, Z. and Goldfarb, S. (1979). Differing effects of acid versus neutral phosphate therapy of hypercalciuria. Kidney Int., 16, 736–42

    Article  PubMed  CAS  Google Scholar 

  62. Fraser D., Russell R. G. G., Pohler O., Robertson W. G. and Fleisch H. (1972). The influence of disodium ethane 1-hydroxy-1,1-diphosphonate (EHDP) on the development of experimentally induced urinary stones in rats. Clin. Sci. Mol. Med., 42, 197–207

    CAS  Google Scholar 

  63. Jowsey, J., Riggs, B. L., Kelly, P. J., Hoffman, D. L. and Bordier, P. (1971). The treatment of osteoporosis with disodium ethane-1-hydroxy-1,1-diphosphonate. J. Lab. Clin. Med., 78, 574–84

    PubMed  CAS  Google Scholar 

  64. Pak C. Y. C., Peters P., Hurt G., Kadesky M., Fine M., Reisman, D., Splann, F., Caramela, C., Freeman, A., Britton, F., Sakhaee, K. and Breslau, N. (1981). Is selective therapy of recurrent nephrolithiasis possible? Am. J. Med., 71, 615–22

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Kluwer Academic Publishers

About this chapter

Cite this chapter

Sharman, V.L. (1988). Hypercalciuria. In: Catto, G.R.D. (eds) Calculus Disease. New Clinical Applications, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2617-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-2617-2_2

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7681-4

  • Online ISBN: 978-94-009-2617-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics